- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Website
- omniome.com
- Total Funding
- $120.0M
- Last Round
- $60.0M Series CJan 2020
About
Omniome developed a proprietary short-read DNA sequencing platform based on Sequencing by Binding (SBB) chemistry. Acquired by PacBio in September 2021 for ~$800 million.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account